D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co. is an investment firm founded in 1988 by David E. Shaw, who had been a computer science professor at Columbia University. It started over a small bookstore in downtown New York and became a pioneer in computational finance, using math models and software to profit from market anomalies. Its funds rely heavily on computer-driven methods and its own technology to support fundamental research, and it also makes private equity investments in areas such as technology, wind power and real estate. Shaw ran the firm until 2001, then stepped back from daily involvement to focus on D. E. Shaw Research, where he is chief scientist and heads a research group in computational biochemistry. In the mid-1990s it also set up a brokerage and founded the email provider Juno Online Services. An Executive Committee chaired by Anne Dinning leads the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.45% |
| 2 | Healthcare | 13.78% |
| 3 | Technology | 11.11% |
| 4 | Financials | 10% |
| 5 | Consumer Discretionary | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
YHOO
1
DELISTED
Yahoo Inc
YHOO
| $701M | 1.26% |
19,039,209
+10,915,217
| +134% | +$342M |
2013 Q2
11 quarters
|
|
2
Berkshire Hathaway Class B
BRK.B
$1.16T
| $698M | 1.25% |
4,919,563
-1,313,594
| -21% | -$174M |
2013 Q2
11 quarters
|
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $614M | 1.1% |
2,290,477
+1,385,489
| +153% | +$397M |
2013 Q3
10 quarters
|
|
4
Biogen
BIIB
$36.9B
| $580M | 1.04% |
2,228,217
+135,608
| +6% | +$35.8M |
2013 Q2
11 quarters
|
|
|
5
Booking.com
BKNG
$113B
| $476M | 0.86% |
9,241,700
+4,571,375
| +98% | +$219M |
2013 Q2
11 quarters
|
|
|
TWX
6
DELISTED
Time Warner Inc
TWX
| $464M | 0.83% |
6,400,745
+699,514
| +12% | +$48.2M |
2013 Q2
11 quarters
|
|
7
James River Group Holdings
JRVR
$181M
| $453M | 0.81% |
14,047,238
| – | – |
2014 Q4
5 quarters
|
|
8
Humana
HUM
$50.1B
| $448M | 0.8% |
2,446,473
+179,642
| +8% | +$31.2M |
2013 Q2
11 quarters
|
|
9
Amgen
AMGN
$249B
| $446M | 0.8% |
2,973,952
+446,710
| +18% | +$66.4M |
2013 Q2
11 quarters
|
|
|
10
PUT
Booking.com
BKNG
$113B
| $409M | 0.73% |
7,925,000
-4,612,500
| -37% | -$221M |
2013 Q2
11 quarters
|
|
|
11
Citigroup
C
$208B
| $392M | 0.7% |
9,401,149
+6,215,979
| +195% | +$260M |
2013 Q2
11 quarters
|
|
12
Cigna
CI
$78.9B
| $381M | 0.68% |
2,775,866
+514,822
| +23% | +$70.7M |
2014 Q4
5 quarters
|
|
13
Alphabet (Google) Class C
GOOG
$3.45T
| $375M | 0.67% |
10,058,300
-3,256,580
| -24% | -$117M |
2013 Q2
11 quarters
|
|
|
TWC
14
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $369M | 0.66% |
1,803,930
-458,487
| -20% | -$86.7M |
2013 Q3
10 quarters
|
|
15
Intel
INTC
$487B
| $355M | 0.64% |
10,986,229
+2,124,554
| +24% | +$65.2M |
2013 Q2
11 quarters
|
|
|
16
Bank of America
BAC
$354B
| $350M | 0.63% |
25,860,645
+23,868,960
| +1,198% | +$322M |
2013 Q2
11 quarters
|
|
17
PayPal
PYPL
$47.3B
| $341M | 0.61% |
8,823,345
-2,880,641
| -25% | -$104M |
2015 Q3
2 quarters
|
|
18
Pfizer
PFE
$171B
| $328M | 0.59% |
11,672,787
+2,970,845
| +34% | +$84.9M |
2013 Q2
11 quarters
|
|
19
Alphabet (Google) Class A
GOOGL
$3.47T
| $319M | 0.57% |
8,375,180
-2,348,700
| -22% | -$86.5M |
2015 Q4
1 quarter
|
|
20
VeriSign
VRSN
$27.4B
| $313M | 0.56% |
3,529,767
-202,451
| -5% | -$16.5M |
2013 Q2
11 quarters
|
|
21
Teva Pharmaceutical Industries Limited
TEVA
$48.4B
| $310M | 0.56% |
5,801,263
+1,790,797
| +45% | +$105M |
2013 Q2
11 quarters
|
|
22
Eli Lilly
LLY
$1.22T
| $304M | 0.55% |
4,225,405
+1,361,905
| +48% | +$103M |
2013 Q2
11 quarters
|
|
23
Walmart Inc
WMT
$962B
| $299M | 0.54% |
13,106,043
-474,783
| -3% | -$10.4M |
2013 Q2
11 quarters
|
|
24
Marathon Petroleum
MPC
$121B
| $298M | 0.53% |
8,010,123
-4,296,737
| -35% | -$163M |
2013 Q2
11 quarters
|
|
25
Coca-Cola
KO
$399B
| $297M | 0.53% |
6,403,914
+2,843,494
| +80% | +$124M |
2013 Q2
11 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $3.34B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 29% a quarter earlier, followed by Healthcare and Technology.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.